Get the Stockscreener App
508.13
4.14%
20.20
Pre-market:
507.97
-0.16
-0.03%
Intuitive Surgical Inc stock is traded at $508.13, with a volume of 2.28M.
It is up +4.14% in the last 24 hours and down -0.09% over the past month.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
See More
Previous Close:
$487.93
Open:
$490.82
24h Volume:
2.28M
Relative Volume:
1.02
Market Cap:
$172.95B
Revenue:
$8.71B
Net Income/Loss:
$2.48B
P/E Ratio:
74.51
EPS:
6.82
Net Cash Flow:
$1.75B
1W Performance:
+5.26%
1M Performance:
-0.09%
6M Performance:
-0.68%
1Y Performance:
+35.50%
1-Day Range:
$489.43
$511.75
1-Week Range:
$463.05
$517.31
52-Week Range:
$367.38
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Name
Intuitive Surgical Inc
Sector
Industry
Phone
(408) 523-2100
Address
1020 KIFER ROAD, SUNNYVALE
Compare ISRG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
508.13 | 172.95B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
204.45 | 58.70B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
94.68 | 45.77B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
236.10 | 31.27B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
82.58 | 16.45B | 3.90B | 392.30M | 288.10M | 1.95 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-02-24 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jul-10-24 | Reiterated | Citigroup | Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Nov-17-23 | Initiated | HSBC Securities | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-19-23 | Reiterated | BTIG Research | Buy |
| Apr-19-23 | Reiterated | BofA Securities | Buy |
| Apr-19-23 | Reiterated | Citigroup | Buy |
| Apr-19-23 | Reiterated | Evercore ISI | In-line |
| Apr-19-23 | Reiterated | JP Morgan | Overweight |
| Apr-19-23 | Reiterated | Morgan Stanley | Equal-Weight |
| Apr-19-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-19-23 | Reiterated | Raymond James | Outperform |
| Apr-19-23 | Reiterated | Stifel | Buy |
| Apr-19-23 | Reiterated | Truist | Buy |
| Apr-19-23 | Reiterated | Wells Fargo | Overweight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-23-23 | Initiated | William Blair | Outperform |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-13-22 | Initiated | Mizuho | Neutral |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-25-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-25-22 | Downgrade | Redburn | Buy → Neutral |
| Jan-21-22 | Reiterated | BTIG Research | Buy |
| Jan-21-22 | Upgrade | Citigroup | Neutral → Buy |
| Jan-21-22 | Reiterated | Deutsche Bank | Hold |
| Jan-21-22 | Reiterated | Evercore ISI | In-line |
| Jan-21-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-21-22 | Reiterated | Piper Sandler | Neutral |
| Jan-21-22 | Reiterated | Raymond James | Outperform |
| Jan-21-22 | Reiterated | Robert W. Baird | Outperform |
| Jan-21-22 | Reiterated | Stifel | Buy |
| Jan-21-22 | Reiterated | UBS | Neutral |
| Jan-21-22 | Reiterated | Wells Fargo | Overweight |
| Jan-10-22 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Jul-21-21 | Reiterated | BofA Securities | Neutral |
| Jul-21-21 | Reiterated | Citigroup | Buy |
| Jul-21-21 | Reiterated | JP Morgan | Overweight |
| Jul-21-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Jul-21-21 | Reiterated | Piper Sandler | Neutral |
| Jul-21-21 | Reiterated | SVB Leerink | Mkt Perform |
| Jul-21-21 | Reiterated | Stifel | Buy |
| Jul-21-21 | Reiterated | UBS | Neutral |
| Jul-21-21 | Reiterated | Wells Fargo | Overweight |
| Jul-14-21 | Reiterated | Goldman | Buy |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Apr-21-21 | Upgrade | Oppenheimer | Underperform → Perform |
| Apr-21-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-01-21 | Initiated | Citigroup | Buy |
| Dec-15-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-28-20 | Initiated | Argus | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jul-20-20 | Reiterated | Bernstein | Outperform |
| Apr-28-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-17-20 | Downgrade | CFRA | Hold → Sell |
| Apr-17-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-09-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Apr-01-20 | Downgrade | Oppenheimer | Perform → Underperform |
| Jan-27-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-19 | Reiterated | Wells Fargo | Outperform |
| Nov-21-19 | Initiated | Oppenheimer | Perform |
| Jul-19-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-22-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-02-19 | Initiated | Deutsche Bank | Buy |
| Oct-31-18 | Reiterated | Piper Jaffray | Overweight |
| Oct-19-18 | Upgrade | Canaccord Genuity | Hold → Buy |
View All
Intuitive Surgical Inc Stock (ISRG) Latest News
Is Intuitive Surgical a Buy After Volatile Reaction to Earnings? - MarketBeat
What's Next For Intuitive Surgical Stock After An Upbeat Q1? - Nasdaq
Intuitive surgical projects 15%-17% procedure growth for 2025 amid strong Q1 results - MSN
Intuitive Surgical Q1 2025 slides: 19% revenue growth amid da Vinci 5 rollout - Investing.com UK
US-China Tariffs to Squeeze Intuitive Surgical's Margins - Medical Device and Diagnostic industry
Intuitive Surgical, Inc. (NASDAQ:ISRG) Q1 2025 Earnings Call Transcript - Insider Monkey
Results: Intuitive Surgical, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Yahoo Finance
It Looks Like Shareholders Would Probably Approve Intuitive Surgical, Inc.'s (NASDAQ:ISRG) CEO Compensation Package - simplywall.st
Intuitive warns of escalating tariff impact through 2025, despite strong Q1 - Yahoo Finance
Surgical Robot Maker to Become City’s Biggest Employer with $540M Campus Expansion - Peachtree Corners Magazine
Is Intuitive Surgical Stock a Buy? - MSN
Barclays Adjusts Price Target for Intuitive Surgical (ISRG) After Q1 Report | ISRG Stock News - GuruFocus
Intuitive Surgical price target lowered to $635 from $684 at Barclays - TipRanks
Healthcare Metaverse Market Top Companies Study Intuitive - openPR.com
Decoding Intuitive Surgical Inc (ISRG): A Strategic SWOT Insight - GuruFocus
Intuitive Surgical’s Earnings Call Highlights Robust Growth - TipRanks
INTUITIVE SURGICAL INC SEC 10-Q Report - TradingView
Intuitive Surgical sees FY25 capital expenditures $650M-$750M - Yahoo Finance
Analysts Remain Bullish On Intuitive Surgical Despite Macro Uncertainty - Benzinga
Robotics Stock Shrugs Off Tariffs News With Rebound - Investor's Business Daily
Intuitive Surgical (ISRG) Rebounds on Potential Tariff Reductions and Strong Q1 Performance - GuruFocus
Enphase earnings, bullish Duolingo call, Intuitive Surgical outlook - Yahoo Finance
These Analysts Lower Their Forecasts On Intuitive Surgical After Q1 Earnings - Benzinga
Intuitive Surgical stock target cut to $605 at RBC Capital By Investing.com - Investing.com Nigeria
What’s Next For Intuitive Surgical Stock After An Upbeat Q1? - Trefis
Intuitive lowers profit margin forecast due to tariff pressure - MedTech Dive
Stifel maintains Intuitive Surgical buy with $670 target - Investing.com
Intuitive posts strong first-quarter earnings as tariffs set to squeeze margins - Fierce Biotech
Intuitive Surgical Stock Is Surging. Tariffs Could Be Less of a Threat. - MSN
Intuitive Surgical stock target cut to $605 at RBC Capital - Investing.com
Earnings: Intuitive Surgical (ISRG) reports higher revenue and profit for Q1 2025 - AlphaStreet
Why Intuitive Surgical, Inc. (ISRG) is Among the Best Stocks That Will Always Grow - Insider Monkey
ISRG Earnings: Intuitive Surgical’s Financial Results Top Wall Street Estimates - MSN
Piper Sandler cuts Intuitive Surgical target to $575 By Investing.com - Investing.com India
Intuitive Surgical Reverses As Investors Digest Its Conservative Tariffs-Tied View - MSN
Truist cuts Intuitive Surgical stock target to $590, maintains Buy - Investing.com
Raymond James cuts Intuitive Surgical target to $592 By Investing.com - Investing.com India
Intuitive Surgical (ISRG) Price Target Lowered Despite Strong Procedure Growth | ISRG Stock News - GuruFocus
Intuitive Surgical (ISRG) Target Price Trimmed by Truist Amid Q3 Review | ISRG Stock News - GuruFocus
BTIG cuts Intuitive Surgical target to $542, keeps Buy rating By Investing.com - Investing.com Nigeria
Intuitive Surgical warns of tariff impact after upbeat quarterly earnings (April 22) - MSN
BTIG Adjusts Price Target on Intuitive Surgical to $542 From $560, Maintains Buy Rating - marketscreener.com
Intuitive Surgical (ISRG) Price Target Adjusted Amid Strong Q1 P - GuruFocus
Salesforce, AbbVie, Intuitive Surgical And An Industrial Stock On CNBC's 'Final Trades' - Benzinga
Bernstein cuts Intuitive Surgical target to $675, keeps Outperform By Investing.com - Investing.com India
Intuitive Surgical (ISRG) Price Target Adjusted Amid Strong Q1 Performance | ISRG Stock News - GuruFocus
Intuitive Surgical (ISRG) Price Target Reduced by Baird Analyst | ISRG Stock News - GuruFocus
Intuitive Surgical price target lowered to $575 from $670 at Piper Sandler - TipRanks
Leerink cuts Intuitive Surgical stock target to $539, keeps Outperform - Investing.com
Tariffs Trim Intuitive Surgical's 2025 Profit Margins - Finimize
Leerink cuts Intuitive Surgical stock target to $539, keeps Outperform By Investing.com - Investing.com India
Intuitive Surgical Inc Stock (ISRG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):